PITTSBURGH, PA October 2, 2012 – Gateway Analytical announced today the expansion of their analytical testing and consulting services for orally inhaled and nasal drug products (OINDPs) and a new line of testing services for semi-solid drug products such as gels, ointments and creams. These new offerings will compliment many of the services currently provided by the company.
Experts at Gateway Analytical have specialized training in microscopy, spectroscopy and chemical imaging. This expertise has been leveraged for analysis of OINDPs and semi-solid products to quickly and non-invasively characterize the morphology, particle size, composition and spatial distribution of a drug product; providing critical feedback necessary to ensure a product’s quality and efficacy before it is release to market.
“We are excited to provide our clients with our expanded analytical testing services that traditionally have only been available in an R&D laboratory setting,” said David Exline, Senior Vice President of Gateway Analytical. “The novel techniques utilized in these services will prove to be a cost effective and efficient means of testing in a mainstream laboratory setting for all stages of the drug product development life cycle.”
The analytical testing and consulting services provided by Gateway Analytical go toward support of companies during product development of innovative or generic drug products, quality testing, or submission of information to the FDA.
About Gateway Analytical
Gateway Analytical, LLC provides solution-driven analytical testing and consulting services to businesses in the pharmaceutical, materials science and forensics industries. A trusted voice in product efficacy and quality, the Gibsonia, PA company offers conventional and innovative analytical testing techniques that give clients a competitive edge in the marketplace.
Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.